Clinical trials
Pneumonia, Ventilator-Associated trials in the United States with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 2 |
| Active, not recruiting | 1 |
| Terminated | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Massachusetts General Hospital | 2 |
| St. Joseph's Hospital and Medical Center, Phoenix | 2 |
| University of Florida | 2 |
| Angulus, LLC | 1 |
| Barnes-Jewish Hospital | 1 |
| Denver Health and Hospital Authority | 1 |
| Endeavor Health | 1 |
| Harvard Pilgrim Health Care | 1 |
| Johns Hopkins University | 1 |
| Joshua Swan | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pneumonia, Ventilator-Associated | 20 |
| Wounds and Injuries | 2 |
| Airway Obstruction | 1 |
| Bronchopulmonary Dysplasia | 1 |
| Catheter-Related Infections | 1 |
| Communicable Diseases | 1 |
| Critical Illness | 1 |
| Cross Infection | 1 |
| Enterocolitis, Necrotizing | 1 |
| Healthcare-Associated Pneumonia | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.